Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC
PURITAN MEDICAL

Tobacco Virus Protects Against Parkinson’s Disease

By BiotechDaily International staff writers
Posted on 15 Apr 2013
A virus typically associated with tobacco, but also present in spinach, tomatoes, petunias, and other household plants and vegetables, may help protect people from Parkinson’s disease.

Researchers from the University of Louisville’s (UofL; KY, USA) departments of neurology and physiology in a study published on April 3, 2013, in the journal PLOS One revealed that men who smoke have antibodies to the tobacco mosaic virus (TMV). These antibodies may interact with a protein in a cell’s energy generation system and inhibit the development of Parkinson’s disease.

Significantly, according to the researchers, this is the first reporting of the presence of antibodies to TMV in humans. Ruolan Liu, MD, PhD, Radhika Vaishnav, PhD, Andrew Roberts, PhD, and Robert Friedland, MD, examined blood samples of 60 men, 20 each who were smokeless tobacco users, smokers, or non-tobacco users. The researchers found the highest levels of the antibodies to TMV in those who smoked.

“It is quite remarkable that a plant that creates so many health problems for people may harbor a virus that has a protective role for people,” remarked Dr. Friedland, professor of neurology at the University of Louisville and the senior author for the study. “We still have a significant amount of research to undertake to determine what mechanisms may be involved, the molecular pathways that are in play and much more. However, it is valuable to consider the potential implications of plant viruses to human health and disease.”

Related Links:
University of Louisville



Channels

Genomics/Proteomics

view channel
Image: Researchers have generated disease-free stem cells from patients with mitochondrial disease that can be converted into any cell type including neuronal progenitors (left) or heart cells (right). These could potentially be used for future transplantation into patients (Photo courtesy of Salk Institute of Biological Studies).

Methods Developed to Generate Normal Stem Cells from Patients with Mitochondrial Defects

A recent paper described two methods for converting cells from patients with mitochondrial defects into normal pluripotent stem cells that could be induced to differentiate into several different types of tissues.... Read more

Drug Discovery

view channel
Image: A new micelle delivery system for the protective polyphenols resveratrol and quercetin (mRQ) may have value in cancer chemotherapy (Photo courtesy of Oregon State University).

Micelles Containing Resveratrol and Quercetin Reverse Doxorubicin Cardiotoxicity

Cancer researchers blocked the toxic effects of the cancer drug doxorubicin (DOX) by administering it together with the plant antioxidants resveratrol and quercetin. Although in use for more than 40... Read more

Lab Technologies

view channel
Image: The Leica DM2500 LED Microscope for clinical laboratories and research applications (Photo courtesy of Leica Microsystems).

New LED Microscope Completes Line of Clinical and Research Tools

A popular microscope used for both clinical and research applications is now available with LED illumination. The Leica (Wetzlar, Germany) DM2500 and DM2500 LED microscopes represent a class of tools... Read more

Business

view channel

Teva Buys Allergan Generic Business Unit

Teva Pharmaceutical Industries (Petah Tikva, Israel) has bought the Allergan (Irvine, CA, USA) generic drugs business for USD 40.5 billion in cash and stock, solidifying its position as the world's largest generic drug maker. Under the terms of the agreement, Teva will pay USD 33.75 billion in cash and USD 6.... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.